RxCell has received a US patent for an iPSC-based cell therapy approach, a method of generating multiple cellular therapy ...

Queen Mary University of London is delighted to be a part of the new London-based Advanced Therapy Treatment Centre (ATTC).

Rocket Pharmaceuticals announced enrollment completion for phase 2 study using its gene therapy RP-A501 for treatment of male ...

Imperial to join ATTC NetworkImperial has joined the Advanced Therapies Treatment Centre (ATTC) Network which aims to accelerate the delivery of cell ...

Shares dropped by as much as one-quarter Thursday after the biotech shared longer-term results for a gene therapy it’s developing for wet AMD.

Jenssen guessed then that two of her daughters, the twins, had a Duchenne mutation, and she knew in her heart that, for at ...

ScaleReadyTM, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReadyTM, today announced that ImmunoScape (a Singapore-U.S. based TCR-T therapy company) ...

The tumor microenvironment (TME) is a major obstacle that limits effective cancer treatments. Various cells around the tumor promote immunosuppression and | Immunology ...

The Gene Therapy segment focuses on the gene therapy approach to introduce ... using small drug molecules that bind to the melanocortin receptors on human cells and affect skin pigmentation and other ...

RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic disorders and cancer due to ...

FN Media Group News Commentary - Breast cancer is an illness in which the breast cells get uncontrollably large. The type of breast cancer depends on which cells in the breast become cancerous. Cancer ...

New Novartis data in relapsing MS reinforce benefits of Kesimpta for first-line and switch patients: Basel Friday, September 20, 2024, 12:00 Hrs [IST] Novartis announced new data ...